Buy NVO by Aug 5, 2026.

[https://www.law360.com/articles/2474744/novo-nordisk-beats-sanofi-to-keep-injection-pen-patent](https://www.law360.com/articles/2474744/novo-nordisk-beats-sanofi-to-keep-injection-pen-patent) Law360, London (May 7, 2026, 6:32 PM BST) -- Novo Nordisk can keep a patent for an injection device with a display panel showing the dose given to a patient, as European appellate officials dismissed claims from Sanofi-Aventis and Medmix that the device was obvious based on earlier devices. A board of appeal at the European Patent Office ruled in a decision on March 19, just made public, that Novo Nordisk could keep amended claims for its patented device …